153OResponse rate by geographic region in patients with hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer from the SOLAR-1 trial. (13th May 2019) - Loibl, S; Conte, P F; Campone, M; Mayer, I; Lu, Y-S; Denduluri, N; Wilke, C; Ridolfi, A; André, F